This topic contains a solution. Click here to go to the answer

Author Question: A limitation of research linking optimism and better health outcome is that it ______. a. has not ... (Read 59 times)

krzymel

  • Hero Member
  • *****
  • Posts: 548
A limitation of research linking optimism and better health outcome is that it ______.
 
  a. has not been conducted on children and adolescents
  b. has only involved hospitalized patients
  c. has been correlational
  d. has focused almost exclusively on females

Question 2

A class of medications which enhances GABA's calming effect are ______.
 
  a. phenothiazines c. neuroleptics
   b. benzodiazepines d. hallucinogenics



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

chereeb

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

C

Answer to Question 2

B




krzymel

  • Member
  • Posts: 548
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)


mohan

  • Member
  • Posts: 362
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library